These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3771963)

  • 1. The Contin delivery system: dosing considerations.
    Leslie S
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):768-73. PubMed ID: 3771963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of once-daily Uniphyl tablets administered in the morning or evening with baseline twice-daily theophylline therapy in patients with nocturnal asthma.
    Grossman J
    Am J Med; 1988 Jul; 85(1B):11-3. PubMed ID: 3041821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.
    Goldenheim PD; Conrad EA; Schein LK
    Chronobiol Int; 1987; 4(3):397-408. PubMed ID: 3315269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma.
    Arkinstall WW
    Am J Med; 1988 Jul; 85(1B):60-3. PubMed ID: 3400688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of food-induced changes in the absorption of theophylline from Uniphyl tablets.
    Arkinstall WW; Hopkinson M; Rivington RN; Calcutt L; Aitken T; Stewart JH
    J Allergy Clin Immunol; 1988 Aug; 82(2):155-64. PubMed ID: 3273483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a uniform round-the-clock theophylline blood level necessary for optimal asthma therapy in the adolescent patient?
    Bierman CW; Pierson WE; Shapiro GG; Furukawa CT
    Am J Med; 1988 Jul; 85(1B):17-20. PubMed ID: 3041822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation.
    Rivington RN; Calcutt L; Child S; MacLeod JP; Hodder RV; Stewart JH
    Am J Med; 1985 Dec; 79(6A):67-72. PubMed ID: 4083303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma.
    Busse WW; Bush RK
    Am J Med; 1985 Dec; 79(6A):62-6. PubMed ID: 4083302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline levels and clinical response in asthmatic adults receiving long-term Uniphyl.
    Petty TL; Rollins DL
    Am J Med; 1985 Dec; 79(6A):73-6. PubMed ID: 2867679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
    Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved control of asthma in the office setting. A large-scale study of once-daily evening doses of theophylline.
    Helm SG; Meltzer SM
    Am J Med; 1988 Jul; 85(1B):30-3. PubMed ID: 3041824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily evening administration of Uniphyl tablets: announcement of first available chronotherapy of nocturnal asthma.
    Goldenheim PD
    Chronobiol Int; 1989; 6(3):199-201. PubMed ID: 2805149
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of a single daily theophylline dose and metered-dose albuterol in asthma treatment.
    Busse WW; Smith A; Bush RK
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):577-82. PubMed ID: 3771949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of once-a-day theophylline dose to match peak blood level with diurnal variation in severity of asthma.
    Welsh PW; Reed CE; Conrad E
    Am J Med; 1986 Jun; 80(6):1098-102. PubMed ID: 3728507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
    Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated dosing of Uniphyl tablets under fed and fasting conditions: comparison of serum theophylline levels, pulmonary function, and asthma symptoms.
    Arkinstall WW; Brar PS; Stewart JH
    Ann Allergy; 1991 Dec; 67(6):583-7. PubMed ID: 1750720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of once-a-day and twice-a-day theophylline in asthma.
    Fairshter RD; Lowe JE; Wilson AF; Salness K; Novey HS
    Respiration; 1986; 50(3):193-201. PubMed ID: 3797827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.